Back

Effects of once-weekly exenatide on clinical outcomes in the subgroup of patients with pre-existing cardiovascular disease: insights from EXSCEL

28 August 2018 (11:00 - 11:13)
Organised by:
Congress Presentation Part of: Management of coronary disease: temporal trends and residual risk Clinical ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Robert Mentz

Duke University Medical Center, Durham (United States of America)

6 More presentations in this session

Presentation thumbnail
Trends and outcomes of use of coronary angiography in management of non-ST-Elevation acute coronary syndromes (NSTEACS), a population based cohort study
Doctor M. Rashid (Stoke-on-Trent, GB)
Abstract Slides Video
Presentation thumbnail
Continuing decline in incidence of recurrent myocardial infarction, stroke, and death following first myocardial infarction: a 15-year nationwide cohort study
Doctor T. Sehested (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: a population-based cohort study
Doctor J. Tran (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Linear ongoing risk of major cardiovascular events in a global prospective registry of high-risk patients with stable coronary disease: insights from the TIGRIS study
Professor D. Brieger (Concord, AU)
Abstract Slides Video
Presentation thumbnail
Identifying higher risk patients among the COMPASS-Eligible population: An analysis from the REduction of atherothrombosis for continued health (REACH) Registry
Doctor A. Darmon (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Management of coronary disease: temporal trends and residual risk

The Event

Event poster

ESC Congress 2018

28 August 2018 11:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources